VeriSIM Life Earns Frost & Sullivan Competitive Strategy Leadership Award For Best Practices In AI-Enabled Preclinical Development Industry
December 14, 2022
December 14, 2022
SAN ANTONIO, Texas, Dec. 14 (TNSres) -- Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services across multiple industries, issued the following news release:
VeriSIM Life eliminates waste and inaccuracy, accelerates preclinical development, and lowers costs and risks when converting drug candidates to clinical trials, and brings life-saving drugs to market faster.
Frost & Sullivan recently assessed . . .
VeriSIM Life eliminates waste and inaccuracy, accelerates preclinical development, and lowers costs and risks when converting drug candidates to clinical trials, and brings life-saving drugs to market faster.
Frost & Sullivan recently assessed . . .